Hovione has appointed Dr. Mike Ironside general manager of TTC in NJ. Dr. Ironside previously held positions with GSK in the UK and AMRI, and most recently with Anacor Pharmaceuticals, where he served as vice president of Chemical Manufacture and Development.
 
Dr. Ironside has more than 20 years of experience in the development and scale-up of APIs from lead candidate optimization through to NDA submission and commercialization. He also has extensive experience in the management of scientific and operational teams in Biotech and CRO environments.
 
“This is a key appointment at an important time for Hovione. We are certain that Dr. Ironside’s leadership qualities combined with his relevant experience in chemical and analytical process development, scale-up from Pilot Plant to full commercial scale will enable us to further strengthen and enlarge our US operations in New Jersey and add new approaches to solve our customers’ most challenging problems,” said Dr. Thomas Eisele, vice president corporate R&D.